Skip to content

IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis

IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02175134
Enrollment
2
Registered
2014-06-26
Start date
2014-07-31
Completion date
2018-06-30
Last updated
2018-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected Tuberculous Peritonitis

Keywords

tuberculosis, peritonitis, laparoscopy

Brief summary

The diagnosis of tuberculous peritonitis (TBP) is still challenging, and largely dependent on invasive procedures such as laparoscopy. A recently developed RD-1 gene-based assay for diagnosing TBP shows has given promising results. The investigators thus created a 2-step algorithm using the Blood/Ascites ELISPOT assays and adenosine deaminase (ADA) in ascites for differentiation of TBP from other diagnoses (Blood ELISPOT ≥6 spots or ADA ≥ 21 U/L' as a rule-out test and 'Ascites/Blood ratio ≥3' as a rule-in test). This study is the randomized controlled trial on whether this 2-step algorithm-based approach can reduce the laparoscopic biopsy for the diagnosis of TBP in patients with suspected TBP.

Interventions

OTHERBlood and Ascites ELISPOT

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all patients with suspected tuberculous peritonitis * age 16 or more * formal informed consent

Exclusion criteria

* not specified

Design outcomes

Primary

MeasureTime frame
the frequency of laparoscopic biopsy1 week after the enrollment

Secondary

MeasureTime frameDescription
the frequency of correct or wrong diagnosis6 months after the enrollmentthe frequency of correct or wrong diagnosis

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026